Absci Corporation ABSI EBITDA

EBITDA at other companies

SchrodingerSDGR

-$40.06M+22.0%

Recursion Pharmaceuticals, Inc.RXRX

-$116.8M+23.3%

AbCellera Biologics Inc.ABCL

-$55.79M-26.5%

AnaptysBio, Inc.ANAB

-$34.51M-26.0%

Assembly BiosciencesASMB

-$11.34M-14.5%

Spyre Therapeutics, Inc.SYRE

——

FAQ

What is Absci Corporation's EBITDA?

Absci Corporation (ABSI) reported EBITDA of -$28.12M in Q1 2026.

How has Absci Corporation's EBITDA changed year-over-year?

Absci Corporation's EBITDA decreased by 14.0% year-over-year, from -$24.66M to -$28.12M.

What is the long-term trend for Absci Corporation's EBITDA?

Over 4 years (2021 to 2025), Absci Corporation's EBITDA has grown at a 12.2% compound annual growth rate (CAGR), from -$68.58M to -$108.58M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.